#1 Clinical Trials Search in Europe

Celecoxib

Celecoxib, a nonsteroidal anti-inflammatory drug (NSAID), has been the subject of numerous clinical trials to evaluate its effectiveness in treating various medical conditions. This article explores the use of Celecoxib in clinical trials for conditions such as colorectal cancer, osteoarthritis, rheumatoid arthritis, gout, and sore throat. We’ll examine the drug’s potential benefits, dosing regimens, and safety considerations across different patient populations.

Table of Contents

What is Celecoxib?

Celecoxib is a medication that belongs to a class of drugs called nonsteroidal anti-inflammatory drugs (NSAIDs). It is specifically known as a selective COX-2 inhibitor, which means it targets a specific enzyme in the body responsible for inflammation and pain[1]. Celecoxib is sold under various brand names, including:

  • Celebrex
  • Celebra
  • Celcox
  • MINT-CELECOXIB

It is available in different forms, including capsules and liquid suspensions, and is typically taken orally (by mouth)[2].

How Does Celecoxib Work?

Celecoxib works by inhibiting an enzyme called cyclooxygenase-2 (COX-2). This enzyme is responsible for producing prostaglandins, which are substances in the body that cause inflammation, pain, and fever. By blocking COX-2, Celecoxib reduces inflammation and pain without affecting the protective COX-1 enzyme found in the stomach and intestines[1].

This selective action is what sets Celecoxib apart from traditional NSAIDs like ibuprofen or naproxen, which inhibit both COX-1 and COX-2 enzymes. The selectivity of Celecoxib may result in fewer gastrointestinal side effects compared to non-selective NSAIDs[1].

Conditions Treated with Celecoxib

Celecoxib is used to treat various conditions characterized by pain and inflammation. Based on the clinical trials information provided, Celecoxib has been studied for use in the following conditions:

  1. Osteoarthritis: This is a common form of arthritis where the cartilage that cushions the bones wears down over time, causing pain and stiffness in joints[1].
  2. Rheumatoid Arthritis: An autoimmune disorder that causes inflammation in the joints, leading to pain, swelling, and potential joint damage[3].
  3. Acute Pain: Such as pain following dental procedures or surgery[2].
  4. Colorectal Cancer: Some studies are investigating the potential use of Celecoxib in preventing or treating certain types of colorectal cancer, particularly in high-risk individuals[4].
  5. Obsessive-Compulsive Disorder (OCD): Research is being conducted to explore the potential benefits of Celecoxib as an add-on treatment for OCD in children and adolescents[5].
  6. Head and Neck Cancer: Studies are investigating the use of Celecoxib alongside chemotherapy and radiation therapy for advanced head and neck cancers[6].

Dosage and Administration

The dosage of Celecoxib can vary depending on the condition being treated, the patient’s age, weight, and other factors. Based on the clinical trials information, some common dosages include:

  • For osteoarthritis: 200 mg once daily or 100 mg twice daily[3]
  • For acute pain: 400 mg initially, followed by 200 mg twice daily as needed[2]
  • For children with OCD: 50 mg or 100 mg twice daily, based on weight[5]

It’s important to note that these dosages are examples from clinical trials and may not reflect the dosage your doctor prescribes. Always follow your healthcare provider’s instructions regarding dosage and administration.

Potential Side Effects

Like all medications, Celecoxib can cause side effects. Some potential side effects observed in clinical trials include:

  • Gastrointestinal issues (such as stomach upset or nausea)
  • Headache
  • Dizziness
  • Skin rash
  • Increased risk of cardiovascular events (in some patients with pre-existing conditions)

It’s important to discuss potential side effects with your healthcare provider before starting Celecoxib. They can provide more detailed information based on your individual health status and medical history[2].

Ongoing Research and Potential New Uses

Researchers are continually studying Celecoxib to understand its full potential. Some areas of ongoing research include:

  1. Cancer Prevention and Treatment: Studies are exploring whether Celecoxib could help prevent certain types of cancer or enhance the effectiveness of cancer treatments[7].
  2. Mental Health Conditions: Research is being conducted on the potential use of Celecoxib as an add-on treatment for conditions like obsessive-compulsive disorder[5].
  3. Combination Therapies: Scientists are investigating how Celecoxib might work in combination with other medications to treat various conditions more effectively[8].

It’s important to note that these are areas of ongoing research, and Celecoxib may not be approved for these uses. Always consult with your healthcare provider about the most current and appropriate treatments for your specific condition.

Condition Dosage Duration Key Findings
Colorectal Cancer Prevention (HNPCC) 200mg or 400mg twice daily 12 months Evaluated safety and efficacy in HNPCC patients and carriers
Osteoarthritis (Knee) 400mg initial dose, then 200mg every 12 hours 5 days post-surgery Assessed pain control, rehabilitation results, and narcotic usage
Rheumatoid Arthritis Two tablets twice daily 6 weeks Compared efficacy and safety of CELBESTA® and CELEBREX®
Gout Various dosing regimens 8 days Evaluated efficacy and safety compared to indomethacin
Sore Throat (Pharyngitis) 50mg to 100mg initial dose, with follow-up doses 24 hours Assessed pain relief and onset of action compared to placebo

FAQ

  • What is Celecoxib and how does it work? Celecoxib is a nonsteroidal anti-inflammatory drug (NSAID) that works by blocking an enzyme called cyclooxygenase-2 (COX-2). This action reduces the production of prostaglandins, which are chemicals in the body that cause inflammation, pain, and fever.
  • In which medical conditions has Celecoxib been studied? Celecoxib has been studied in various clinical trials for conditions including colorectal cancer, osteoarthritis, rheumatoid arthritis, gout, and sore throat. It has shown potential benefits in managing pain and inflammation associated with these conditions.
  • What are the common dosages of Celecoxib used in clinical trials? Dosages of Celecoxib vary depending on the condition being treated. In the trials mentioned, doses ranged from 50 mg to 800 mg per day. For example, in osteoarthritis trials, doses of 200 mg twice daily were common, while in sore throat studies, initial doses of 50 mg to 100 mg were used.
  • Are there any safety concerns associated with Celecoxib use? As with all medications, Celecoxib may have side effects. In clinical trials, researchers monitored for gastrointestinal and cardiovascular effects. It's important to note that the safety profile can vary depending on the dosage, duration of use, and individual patient factors.
  • How long do Celecoxib clinical trials typically last? The duration of Celecoxib clinical trials varies widely depending on the condition being studied and the specific research objectives. In the trials mentioned, durations ranged from short-term studies of a few days for acute conditions like sore throat, to longer studies lasting several months or even a year for chronic conditions like osteoarthritis or cancer prevention.

Ongoing Clinical Trials on Celecoxib

  • Study on Spinal vs. General Anaesthesia with Ropivacaine Hydrochloride for Osteoarthritis Patients Undergoing Hip and Knee Replacement

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Denmark

  • Study on the Effectiveness and Safety of AP707 and Naproxen for Patients with Chronic Back Pain

    Not recruiting

    3 1 1
    Investigated drugs:
    Austria Germany

Glossary

  • Celecoxib: A nonsteroidal anti-inflammatory drug (NSAID) that selectively inhibits cyclooxygenase-2 (COX-2) enzyme, used to treat pain and inflammation in various conditions.
  • COX-2 inhibitor: A type of NSAID that specifically targets the cyclooxygenase-2 enzyme, which is involved in inflammation, while sparing the COX-1 enzyme that helps protect the stomach lining.
  • NSAID: Nonsteroidal Anti-Inflammatory Drug, a class of medications that reduce pain, fever, and inflammation.
  • Osteoarthritis: A degenerative joint disease characterized by the breakdown of joint cartilage and underlying bone, often causing pain and stiffness.
  • Rheumatoid Arthritis: An autoimmune disorder that causes inflammation of the joints and surrounding tissues, leading to pain, stiffness, and potential joint deformity.
  • Gout: A form of arthritis caused by the buildup of uric acid crystals in the joints, often affecting the big toe and causing severe pain and inflammation.
  • Pharyngitis: Inflammation of the throat, commonly known as a sore throat, which can cause pain and discomfort when swallowing.
  • Colorectal Neoplasm: An abnormal growth in the colon or rectum that may be benign or cancerous.
  • Hereditary Nonpolyposis Colorectal Cancer (HNPCC): An inherited condition that increases the risk of colorectal cancer and other types of cancer.
  • Visual Analogue Scale (VAS): A measurement tool used to assess subjective characteristics or attitudes that cannot be directly measured, often used for pain assessment.
  • Disease Activity Score in 28 joints (DAS28): A measure of disease activity in rheumatoid arthritis that assesses 28 joints for tenderness and swelling.
  • Placebo: An inactive substance or treatment used in clinical trials as a control to compare with the effects of the active drug being tested.
  • Double-blind study: A research design in which neither the participants nor the researchers know who is receiving the active treatment and who is receiving the placebo.
  • Randomized controlled trial: A type of scientific experiment where participants are randomly allocated to receive either the treatment under investigation or a placebo/standard treatment.

References

  1. https://clinicaltrials.gov/study/NCT01354145
  2. https://clinicaltrials.gov/study/NCT00402987
  3. https://clinicaltrials.gov/study/NCT00484718
  4. https://clinicaltrials.gov/study/NCT01668680
  5. https://clinicaltrials.gov/study/NCT04673578
  6. https://clinicaltrials.gov/study/NCT00603759
  7. https://clinicaltrials.gov/study/NCT00295035
  8. https://clinicaltrials.gov/study/NCT02280694